Clinical trial
RAUORA: Cytisine Versus Varenicline for Smoking Cessation
NCT02957786 is registered in ClinicalTrials.gov with University of Auckland, New Zealand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RAUORA: Cytisine Versus Varenicline for Smoking Cessation
- Lead sponsor
- University of Auckland, New Zealand
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 18, 2017
- Completion date
- October 10, 2019
- Enrollment
- 679 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smoking cessation